GlassScriptPhysician profile
Daxa Mahenda Patel
NPI 1780905398
$576.36
in general payments reported to CMS, 2019-2025
7 companies · $46.92 in 2025
The $46.92 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $34.97 · 2021: $50.38 · 2022: $25.66 · 2024: $213 · 2025: $46.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $315.86 | 2019-2024 | Everest Spinal System, N/A |
| Sumitomo Pharma America, INC. | $69.88 | 2024 | Myfembree |
| Integra Lifesciences Corporation | $69.07 | 2024-2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Evofem Biosciences, INC. | $50.38 | 2021 | |
| Medtronic, INC. | $27.94 | 2025 | Synchromedii |
| Osteomed LLC | $25.66 | 2022 | |
| Amag Pharmaceuticals, INC. | $17.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daxa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.